HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Hans-Willi Krell Selected Research
Hans-Willi Krell Research Topics
Disease
12
Neoplasms (Cancer)
01/2009 - 03/2002
4
Prostatic Neoplasms (Prostate Cancer)
02/2007 - 03/2002
3
Neoplasm Metastasis (Metastasis)
09/2007 - 04/2002
2
Carcinoma (Carcinomatosis)
01/2009 - 02/2007
1
Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome)
12/2011
1
Inflammation (Inflammations)
12/2009
1
Infections
12/2009
1
Ileitis
12/2009
1
Arthritis (Polyarthritis)
01/2006
1
Leukemia
01/2006
1
Carcinogenesis
01/2005
1
Atherosclerosis
08/2004
1
Adenocarcinoma
06/2004
1
Necrosis
03/2004
1
Rupture
12/2003
1
Choroidal Neovascularization
12/2003
1
Macular Degeneration (Age-Related Maculopathy)
12/2003
1
T-Cell Lymphoma (Lymphoma, T Cell)
10/2002
1
Fibrosarcoma
04/2002
Drug/Important Bio-Agent (IBA)
9
Matrix Metalloproteinases (MMPs)
IBA
09/2007 - 03/2002
8
Matrix Metalloproteinase Inhibitors
IBA
02/2007 - 03/2002
6
Ro 28-2653
IBA
02/2007 - 03/2002
3
Enzymes
IBA
01/2006 - 04/2002
2
Antibodies
IBA
12/2011 - 01/2009
2
Gelatinases
IBA
12/2009 - 10/2002
2
Estramustine
FDA Link
02/2007 - 09/2005
2
pyrimidine
IBA
09/2005 - 06/2004
2
batimastat (BB 94)
IBA
06/2004 - 03/2004
2
Matrix Metalloproteinase 2 (Gelatinase A)
IBA
12/2003 - 04/2002
2
Matrix Metalloproteinase 9 (Gelatinase B)
IBA
02/2003 - 04/2002
1
GW 4869
IBA
12/2011
1
Interleukin-22 (IL-22)
IBA
12/2009
1
Interleukin-23 (Interleukin 23)
IBA
12/2009
1
Cytokines
IBA
12/2009
1
Interleukin-17 (Interleukin 17)
IBA
12/2009
1
matriptase
IBA
01/2009
1
Urokinase Plasminogen Activator Receptors
IBA
01/2009
1
Tissue Inhibitor of Metalloproteinase-1
IBA
09/2007
1
Disintegrins
IBA
09/2007
1
Hepatocyte Growth Factor (Growth Factor, Hepatocyte)
IBA
09/2007
1
Peptide Hydrolases (Proteases)
FDA Link
09/2007
1
Etoposide (VP 16)
FDA Link
Generic
02/2007
1
Pharmaceutical Preparations
IBA
02/2007
1
Androgens
IBA
02/2007
1
ADAM17 Protein
IBA
01/2006
1
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
01/2006
1
Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)
IBA
01/2006
1
Neutralizing Antibodies
IBA
01/2006
1
diphenyl (biphenyl)
IBA
09/2005
1
Hormones (Hormone)
IBA
09/2005
1
Herbicides
IBA
01/2005
1
alachlor
IBA
01/2005
1
oxidized low density lipoprotein
IBA
08/2004
1
Angiogenesis Inhibitors
IBA
06/2004
1
Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)
IBA
03/2004
1
Endopeptidases
IBA
03/2004
1
Hydroxamic Acids (Hydroxamic Acid)
IBA
03/2004
1
Protease Inhibitors (Protease Inhibitor)
IBA
03/2004
1
Proteins (Proteins, Gene)
FDA Link
03/2004
1
Sulfhydryl Compounds (Thiols)
IBA
03/2004
1
Zinc
IBA
03/2004
1
Captopril (Capoten)
FDA Link
Generic
03/2004
1
TAPI-2
IBA
03/2004
1
prolyl-leucyl-glycine hydroxamate
IBA
03/2004
1
Metalloproteases (Metalloproteinases)
IBA
03/2004
1
N- (2(R)- 2- (hydroxamidocarbonylmethyl)- 4- methylpentanoyl)- L- tryptophan methylamide
IBA
03/2004
1
astacin
IBA
03/2004
1
Tiopronin (Thiola)
FDA Link
03/2004
1
Gelatin
IBA
02/2003
1
Biomarkers (Surrogate Marker)
IBA
02/2003
Therapy/Procedure
2
Therapeutics
01/2009 - 06/2004
2
Lasers (Laser)
12/2003 - 02/2003
1
Aftercare (After-Treatment)
02/2003
1
Induced Hyperthermia (Thermotherapy)
02/2003